Skip to main content

Climb Bio, Inc.

CLYM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001768446

In the last 90 days, Climb Bio, Inc. insiders filed 0 open-market purchases and 1 sale; 108 institutions reported holding it in 13F filings for Q2 2026, worth $734.3M in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Climb Bio, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of CLYM: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders6968−1
Shares49.9M44.6M−5.26M (−10.5%)
Value$61.9M$89.7M+$27.8M (+45.0%)

New holders (12)

Institutions that held Climb Bio, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to CLYM in Q3 2025
InstitutionSharesValue% of portfolio
LPL Financial LLC61,000$122.6K0.00%
Bluefin Capital Management, LLC59,985$120.6K0.05%
Citizens Financial Group Inc46,000$92.5K0.00%
Prelude Capital Management, LLC40,718$81.8K0.01%
XTX Topco Ltd29,184$58.7K0.00%
Susquehanna Portfolio Strategies, LLC18,272$36.7K0.00%
Walleye Capital LLC15,000$30.1K0.00%
JustInvest LLC14,546$29.2K0.00%
Federated Hermes, Inc.4,420$8.88K0.00%
Harbour Investments, Inc.2,000$4.02K0.00%
SRS Capital Advisors, Inc.53$1060.00%
Advisory Services Network, LLC32$640.00%

Sold out (13)

Institutions that held Climb Bio, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of CLYM in Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
Citadel Advisors LLC138,392$171.6K
Y-Intercept (Hong Kong) Ltd127,952$158.7K
Stonepine Capital Management, LLC116,147$144.0K
AQR Capital Management LLC28,890$35.8K
Jain Global LLC25,693$31.9K
HRT Financial LP18,529$22.0K
SG Americas Securities, LLC13,818$17.0K
Point72 (DIFC) Ltd421$522
Wells Fargo & Company244$303
Raymond James Financial Inc200$248
Essential Partners LLC63$78
True Wealth Design, LLC19$24
Clearstead Advisors, LLC11$14